BBlogFlow

Alberta offers early flu shots as season strikes faster than expected - CFWE

·1d ago

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Alberta health officials have accelerated the flu shot campaign, instructing pharmacies across the province to begin scheduling vaccinations immediately, rather than waiting for the original start date of October 19. According to Primary care Alberta, influenza cases have surged ahead of the typical timeline, leaving hospitals full, and frontline workers unprotected. Provincial data show more than 400 confirmed flu infections so far. Infectious-disease specialist Dr. Lynora Saxinger of the University of Alberta Hospital explains that this year’s dominant strain is circulating vigorously because it differs enough from prior versions that residual immunity offers little defence. She urges people to arrange a shot without delay, stressing that the body needs time to build protection once the vaccine is given. Officials advise Albertans to contact their neighborhood pharmacy first to confirm vaccine availability. High-risk and immunocompromised residents have already started receiving doses. Appointments can also be made online or by calling Health Link at 811.

This article is an excerpt. To read the full content, visit the original source. CFWE

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·